Results 21 to 30 of about 2,261 (229)

A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum

open access: yesInternational Journal of Mycobacteriology, 2019
Hansen's disease is a chronic infectious granulomatous disease with varied clinical presentation. Histoid Hansen's disease is an important emerging lepromatous subset of Hansen's disease known to mimic varied dermatoses.
Vikas Pathania   +5 more
doaj   +1 more source

Diagnosis of Hansen's disease

open access: yesJAPANESE JOURNAL OF LEPROSY, 2011
The Leprosy Mailing List (LML) is an e-mailing list open to whoever interested in the field from all over the world. It acts as a forum for exchanging information related to Hansen's disease. It was established in February 2001 in Italy, and the present moderator of the LML is Dr. Salvatore Noto.
YOTSU, Rie Roselyne   +3 more
openaire   +3 more sources

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

open access: yesHepatology, EarlyView., 2022
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel   +93 more
wiley   +1 more source

A Case of Hansen's Disease.

open access: yesJapanese journal of leprosy, 2003
With the abolition of Leprosy Prevention Act of 1996, that opportunities examining the Hansen's disease patient with a general medical institution increase is expected. Because we experienced Hansen's disease of a staying in Japan foreigner then in such time, we present it.
Wada, Hidefumi   +4 more
openaire   +3 more sources

Spatial approach of leprosy in the State of São Paulo, 2009-2012 [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2019
: Background: Leprosy is a chronic, infectious disease that affects the skin and the peripheral nervous system and can lead to permanent disability and/or deformity. Objectives: To identify the distribution and to quantify the spatial dependence of the
Flávia Regina Ferreira   +1 more
doaj   +1 more source

Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra

open access: yeseLife, 2022
The risk of developing cancer is correlated with body size and lifespan within species, but there is no correlation between cancer and either body size or lifespan between species indicating that large, long-lived species have evolved enhanced cancer ...
Juan Manuel Vazquez   +5 more
doaj   +1 more source

Comparison of Two Mice Strains, A/J and C57BL/6, in Caspase-1 Activity and IL-1β Secretion of Macrophage to Mycobacterium leprae Infection

open access: yesMediators of Inflammation, 2010
A/J mice were found to have amino acid differences in Naip5, one of the NOD-like receptors (NLRs) involved in the cytosolic recognition of pathogen-associated molecular patterns and one of the adaptor proteins for caspase-1 activation.
Tae Jin Kang   +4 more
doaj   +1 more source

PSYCHOLOGICAL DISTRESS AMONG INDIVIDUALS WITH HANSEN'S DISEASE

open access: yesIndian Journal of Psychiatric Nursing, 2017
Hansen's disease is a nonfatal, chronic infectious disease caused by Mycobacterium leprae, whose clinical manifestations are largely confined to the skin, peripheral nervous system, upper respiratory tract and eyes.
ATS Giri   +3 more
doaj   +1 more source

Clinico-histological correlation in Hansen's disease: Three-year experience at a newly established tertiary care center in central India

open access: yesIndian Journal of Dermatology, 2018
Background: Hansen's disease is a chronic infectious disease caused by Mycobacterium leprae. It is characterized by a wide range of clinical and histological manifestations. Ridley–Jopling criteria are widely used for classifying leprosy.
Shruti Semwal   +4 more
doaj   +1 more source

Targeting the ATX‐LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways

open access: yesAdvanced Science, EarlyView.
ABSTRACT Background Therapeutic resistance limits durable survival in advanced/metastatic renal cell carcinoma (RCC) treated with first‐line tyrosine kinase inhibitor (TKI) plus immune checkpoint inhibitor (ICI). We sought to define key resistance drivers and actionable targets.
Jinchen Luo   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy